首页> 美国卫生研究院文献>Healthcare >Laser Photobiomodulation (PBM)—A Possible New Frontier for the Treatment of Oral Cancer: A Review of In Vitro and In Vivo Studies
【2h】

Laser Photobiomodulation (PBM)—A Possible New Frontier for the Treatment of Oral Cancer: A Review of In Vitro and In Vivo Studies

机译:激光光致调节(PBM)-A可能的新前沿用于治疗口腔癌:对体外和体内研究的综述

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

The treatment of oral squamous cell carcinoma (OSCC) is particularly complex due to its aggressive behavior, location, the patient’s age, and its spread at diagnosis. In recent years, photobiomodulation (PBM) has been introduced in different medical fields; however, its application, in patients suffering from OSCC for palliative support or to induce analgesia, has been hotly debated due to the possibility that the cell growth stimuli induced by PBM could lead to a worsening of the lesions. The aim of this study is to review the literature to observe the available data investigating the effect of PBM on cancer cells in vitro and in vivo. A review was conducted on the PubMed and Scopus databases. A total of twelve studies met the inclusion criteria and were therefore included for quality assessment and data extraction. The analysis showed that the clinical use of PBM is still only partially understood and is, therefore, controversial. Some authors stated that it could be contraindicated for clinical use in patients suffering from SCC, while others noted that it could have beneficial effects. According to the data that emerged from this review, it is possible to hypothesize that there are possibilities for PBM to play a beneficial role in treating cancer patients, but further evidence about its clinical efficacy and the identification of protocols and correct dosages is still needed.
机译:由于其侵略性行为,位置,患者的年龄及其在诊断中的蔓延,口腔鳞状细胞癌(OSCC)的治疗特别复杂。近年来,光生物调节(PBM)已在不同的医疗领域引入;然而,它的应用,患有痛苦支持或诱导镇痛的OSCC的患者,由于PBM诱导的细胞生长刺激可能导致病变恶化而受到热烈讨论。本研究的目的是审查文献,以观察在体外和体内调查PBM对癌细胞影响的可用数据。在PubMed和Scopus数据库上进行了审查。共有十二项研究达到了纳入标准,因此包括质量评估和数据提取。分析表明,PBM的临床应用仍然仅部分地理解,因此是有争议的。有些作者表示,它可以禁止患有SCC的患者的临床用途,而其他作者则指出它可能具有有益的效果。根据本综述中出现的数据,可以假设PBM有可能在治疗癌症患者中发挥有益作用,但仍然需要进一步的临床疗效和鉴定和鉴定和正确剂量的证据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号